Recognising the importance of plasma and with over 60 years of experience in the industry, BPL supplies high-quality plasma-derived medicines to meet the needs of clinicians, patients and customers globally.
Headquartered in Elstree, in the UK, and with plasma collection centres across the US, BPL is dedicated to producing a range of medicines for the treatment of immune deficiencies, bleeding disorders and infectious diseases as well for critical care.
BPL in its present form was created in 2010, but its heritage stretches back to the early pioneers of blood and plasma-derived medicines in the UK.
Our five values are at the heart of how we operate as a business, and define what matters to us most.
BPL’s leadership team has been built up with an emphasis on industry expertise across the life science and pharmaceutical sectors, supported by the team’s broad experience working for leading international companies.
Driven by our mission to enhance the lives of our patients, we are focused on providing high-quality products which deliver positive patient outcomes.